ˌɛmdˌiːˈɑːɹɹˌɛspˈiː ɪŋklˈuːdz ˈaɪsəlˌeɪts pɹˈiːviəsli nˈoʊn æz pˌiːˌɑːɹɹˌɛspˈiː pˌɛnɪsˈɪlᵻnɹᵻsˈɪstənt stɹˈɛptəkˌɑːkəs nuːmˈoʊnɪˌiː, ænd ɑːɹ stɹˈeɪnz ɹᵻsˈɪstənt tə tˈuː ɔːɹ mˈoːɹ ʌvðə fˈɑːloʊɪŋ ˌæntɪbaɪˈɑːɾɪks: pˌɛnɪsˈɪlᵻn, sˈɛkənd dʒˌɛnɚɹˈeɪʃən sˈɛfɐlˌɑːspoːɹˌɪnz, ˈiː.dʒˈiː., sˈɛfjʊɹɹˌɑːksaɪm, mˈækɹəlˌaɪdz, tˈɛtɹɐsˌaɪklaɪnz ænd tɹˈaɪmɪθˌɑːpɹɪm slˈæʃ sˈʌlfɐmˌɛθəksˌæzoʊl.
MDRSP includes isolates previously known as PRSP (penicillin-resistant Streptococcus pneumoniae), and are strains resistant to two or more of the following antibiotics: penicillin, 2nd generation cephalosporins, e.g., cefuroxime, macrolides, tetracyclines and trimethoprim/sulfamethoxazole.